A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...

New research reveals UBX1325's potential to significantly improve vision in diabetic macular edema patients, offering hope ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

A team of three Biomedical Engineering undergraduates from West Chester University (WCU) has taken first place in the ...

A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...

Tech companies have been getting a lot of attention in recent weeks during the up-and-down days on Wall Street. They sometimes are among the stocks seeing the biggest moves. Try This: How To Get a ...

Biotech stock Scholar Rock ( SRRK 2.97%) was popular among investors on Wednesday after a positive new analyst note on the company made the rounds. This resulted in the stock bumping nearly 3% higher ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.

Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paperThe author team ...

Aldeyra Therapeutics' stock rebounds 70%, offering a contrarian opportunity with Reproxalap targeting a $216M market. Learn ...